- Home
- SNGX vs HSCS Comparison
SNGX vs HSCS Comparison
Compare SNGX & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- HSCS
- Stock Information
- Founded
- SNGX 1987
- HSCS 2007
- Country
- SNGX United States
- HSCS United States
- Employees
- SNGX N/A
- HSCS N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- HSCS Medical Specialities
- Sector
- SNGX Health Care
- HSCS Health Care
- Exchange
- SNGX Nasdaq
- HSCS Nasdaq
- Market Cap
- SNGX 10.1M
- HSCS 8.7M
- IPO Year
- SNGX 1987
- HSCS 2022
- Fundamental
- Price
- SNGX $2.86
- HSCS $3.33
- Analyst Decision
- SNGX Strong Buy
- HSCS Strong Buy
- Analyst Count
- SNGX 1
- HSCS 2
- Target Price
- SNGX $6.00
- HSCS $13.00
- AVG Volume (30 Days)
- SNGX 10.2M
- HSCS 80.2K
- Earning Date
- SNGX 11-07-2025
- HSCS 09-09-2025
- Dividend Yield
- SNGX N/A
- HSCS N/A
- EPS Growth
- SNGX N/A
- HSCS N/A
- EPS
- SNGX N/A
- HSCS N/A
- Revenue
- SNGX N/A
- HSCS $4,350.00
- Revenue This Year
- SNGX N/A
- HSCS $13,968.97
- Revenue Next Year
- SNGX N/A
- HSCS $166.67
- P/E Ratio
- SNGX N/A
- HSCS N/A
- Revenue Growth
- SNGX N/A
- HSCS N/A
- 52 Week Low
- SNGX $1.09
- HSCS $2.36
- 52 Week High
- SNGX $6.23
- HSCS $6.47
- Technical
- Relative Strength Index (RSI)
- SNGX 49.77
- HSCS 43.80
- Support Level
- SNGX $2.72
- HSCS $3.24
- Resistance Level
- SNGX $3.11
- HSCS $3.59
- Average True Range (ATR)
- SNGX 0.49
- HSCS 0.23
- MACD
- SNGX -0.10
- HSCS -0.01
- Stochastic Oscillator
- SNGX 3.99
- HSCS 13.04
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.